AI assistant
Tectonic Therapeutic, Inc. — Director's Dealing 2018
Jun 21, 2018
33251_dirs_2018-06-20_386c4de5-0601-4b49-8946-540721d1f93c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2018-06-20
Reporting Person: Atlas Venture Fund X, L.P. (10% Owner)
Reporting Person: ATLAS VENTURE ASSOCIATES X, L.P. (10% Owner)
Reporting Person: Atlas Venture Associates X, LLC (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series Seed Preferred Stock | $ | Common Stock (3333333) | Indirect | ||
| Series A Preferred Stock | $ | Common Stock (12580199) | Indirect | ||
| Series B Preferred Stock | $ | Common Stock (3740239) | Indirect |
Footnotes
F1: All series of Convertible Preferred Stock shall automatically convert on a 4.132-for-1 basis into shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering and have no expiration date
F2: The shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. Each of AVA X LP and AVA X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of its pecuniary interest therein, if any.